MULTI BARRIER REVERSE CONVERTIBLE - SANOFI/NOVARTIS N/PFIZER INC/JOHNSON & JOHNSON Share Price

Certificat

UFXLTQ

CH1186544677

Market Closed - Swiss Exchange 16:20:00 28/05/2024 BST
54.5 CHF -1.96% Intraday chart for MULTI BARRIER REVERSE CONVERTIBLE - SANOFI/NOVARTIS N/PFIZER INC/JOHNSON & JOHNSON
Current month+10.91%
1 month+11.32%
Date Price Change
28/05/24 54.5 -1.96%
24/05/24 55.59 -0.30%
23/05/24 55.76 -1.10%
22/05/24 56.38 +2.38%

Delayed Quote Swiss Exchange

Last update May 28, 2024 at 04:20 pm

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying NOVARTIS AG
Issuer LEONTEQ
UFXLTQ
ISINCH1186544677
Date issued 27/05/2022
Strike 87.12 CHF
Maturity Today (-0 Days)
Parity 0.09 : 1
Emission price 100 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 99.64 CHF
Lowest since issue 48.93 CHF
Spread 5.4 CHF
Spread %0.99%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
100 USD
Average target price
108.2 USD
Spread / Average Target
+8.18%
Consensus
  1. Stock Market
  2. Certificates
  3. UFXLTQ Certificat